Condition
Aorto-iliac Aneurysm
Total Trials
8
Recruiting
1
Active
1
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
12.5%
1 terminated out of 8 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results80% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Not Yet Recruiting1
Terminated1
Unknown1
Recruiting1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Showing 8 of 8 trials
NCT07096388Not Yet RecruitingPrimary
Evaluation Of Cost-Effectiveness Of Iliac Branch Endoprostheses
NCT06946381RecruitingPrimary
CAMpania PugliA bRanch Iliaco
NCT01990950Not ApplicableCompleted
Fenestrated AAA Endovascular Graft Post-Approval Study
NCT03061825Completed
Zenith Alpha™ Abdominal Endovascular Graft
NCT03686189Not ApplicableUnknownPrimary
Safety and Efficacy Study of Iliac Bifurcation Stent Graft System
NCT01540643Completed
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
NCT01326884Not ApplicableCompleted
Zenith Low Profile AAA Endovascular Graft (ZLP) Clinical Study
NCT01424267Terminated
Zenith® LP Abdominal Aortic Aneurysm (AAA) Post-Market Registry
Showing all 8 trials